{"nct_id":"NCT03248882","title":"Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)","status":"COMPLETED","status_verified_date":"2020-02","start_date":"2017-08-22","start_date_type":"ACTUAL","primary_completion_date":"2019-02-26","primary_completion_date_type":"ACTUAL","completion_date":"2019-03-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}